Company Filing History:
4 out of 3,107 
3 out of 14 Years Active: 2016-2022
Title: The Innovations of Hongbin Zhang: A Focus on HIV-1 Inhibitors
Introduction: Hongbin Zhang is an esteemed inventor based in Kunming, China, known for his significant contributions to the field of pharmaceutical compositions aimed at treating human immunodeficiency virus (HIV) infections. With a total of three patents to his name, his work reflects a dedication to innovative solutions in the biomedical domain.
Latest Patents: Among his notable patents, Zhang has developed the following groundbreaking inventions:
1. **Pyrimidinone-containing Compound**: This patent discloses a pyrimidinone-containing compound, its preparation method, pharmaceutical composition, and application. The compound represented by formula I exhibits promising capabilities as an HIV-1 inhibitor and can be utilized in the treatment of HIV infections.
2. **DACOS-type NNRTIs Amino Acid Ester Derivative**: This patent presents a DACOS-type NNRTIs amino acid ester derivative, detailing its preparation method, pharmaceutical composition, and application. The structure of this derivative, represented by formula I, also functions as an HIV-1 inhibitor, thereby contributing to drug development for treating and/or preventing infections from immunodeficiency viruses.
Career Highlights: Hongbin Zhang has carved a niche for himself in the research community through his tenure at prestigious institutions. Notably, he has been affiliated with the Chinese Academy of Sciences and Yunnan University. His research endeavors reflect an impressive blend of scientific inquiry and practical application, leading to innovative patent filings.
Collaborations: Throughout his career, Zhang has worked alongside notable colleagues such as Yongtang Zheng and Liumeng Yang. These collaborations have enriched his research initiatives, allowing for the exchange of ideas and a broader exploration into the pharmaceutical applications of their discoveries.
Conclusion: As an inventor, Hongbin Zhang is making substantial strides in the fight against HIV through his innovative patents. His work exemplifies the significant impact that dedicated individuals can have on public health, particularly in the realm of infectious disease treatment. The continued evolution of his research promises further advancements in pharmaceutical science and improved health outcomes globally.